For the full 2012 fiscal year, the company’s revenue grew 5 percent to $3.6 billion. Success in the fourth quarter was driven by the company’s medical system’s segment, while the procedural solutions segment met expectations.
The company’s operating expenses were down 7 percent during the fourth quarter, totaling $313 million. The company increased research and development investments by 21 percent to $46 million.
During the fourth quarter, the company’s medical systems segment reached $646 million, driven by record installations in Infusion Systems and double-digit increases in respiratory technologies and dispensing technologies.
More Articles on CareFusion:
CareFusion Releases 11-Guage Vertebral Balloon for Spinal Fracture Treatment
CareFusion Launches AVAmax Vertebral Balloon for Kyphoplasty
